Northern Trust’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,943
| Closed | -$67.1K | – | 4512 |
|
|
2024
Q4 | $67.1K | Buy |
6,943
+55
| +0.8% | +$531 | ﹤0.01% | 4223 |
|
|
2024
Q3 | $128K | Sell |
6,888
-12,126
| -64% | -$225K | ﹤0.01% | 3998 |
|
|
2024
Q2 | $316K | Sell |
19,014
-528
| -3% | -$8.78K | ﹤0.01% | 3678 |
|
|
2024
Q1 | $339K | Buy |
19,542
+882
| +5% | +$15.3K | ﹤0.01% | 3701 |
|
|
2023
Q4 | $292K | Sell |
18,660
-2,027
| -10% | -$31.7K | ﹤0.01% | 3736 |
|
|
2023
Q3 | $1.02M | Sell |
20,687
-1,711
| -8% | -$84.6K | ﹤0.01% | 3287 |
|
|
2023
Q2 | $1.75M | Buy |
22,398
+3,041
| +16% | +$238K | ﹤0.01% | 3081 |
|
|
2023
Q1 | $1.75M | Sell |
19,357
-636
| -3% | -$57.6K | ﹤0.01% | 2993 |
|
|
2022
Q4 | $2.36M | Buy |
19,993
+209
| +1% | +$24.7K | ﹤0.01% | 2912 |
|
|
2022
Q3 | $3.59M | Buy |
19,784
+7,630
| +63% | +$1.38M | ﹤0.01% | 2687 |
|
|
2022
Q2 | $1.09M | Sell |
12,154
-216
| -2% | -$19.4K | ﹤0.01% | 3324 |
|
|
2022
Q1 | $1.92M | Sell |
12,370
-590
| -5% | -$91.6K | ﹤0.01% | 3124 |
|
|
2021
Q4 | $3.86M | Buy |
12,960
+121
| +0.9% | +$36K | ﹤0.01% | 2850 |
|
|
2021
Q3 | $7.4M | Buy |
12,839
+236
| +2% | +$136K | ﹤0.01% | 2487 |
|
|
2021
Q2 | $5.72M | Sell |
12,603
-75
| -0.6% | -$34.1K | ﹤0.01% | 2761 |
|
|
2021
Q1 | $6.82M | Buy |
12,678
+3,410
| +37% | +$1.84M | ﹤0.01% | 2543 |
|
|
2020
Q4 | $8.19M | Sell |
9,268
-25
| -0.3% | -$22.1K | ﹤0.01% | 2380 |
|
|
2020
Q3 | $5.88M | Buy |
+9,293
| New | +$5.88M | ﹤0.01% | 2425 |
|